Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial.
Alexandra J SinclairRyan S OttridgeJames L MitchellCaroline RickRebecca L WoolleyNatalie J IvesPeter NightingaleAlexandra Jean SinclairPublished in: JMIR research protocols (2017)
Clinicaltrials.gov NCT02017444; https://clinicaltrials.gov/ct2/show/NCT02017444 (Archived by WebCite at http://www.webcitation.org/6tVHesN6s).
Keyphrases
- phase ii
- clinical trial
- randomized controlled trial
- open label
- study protocol
- phase iii
- blood pressure
- placebo controlled
- double blind
- computed tomography
- image quality
- dual energy
- contrast enhanced
- magnetic resonance imaging
- positron emission tomography
- systematic review
- optic nerve
- drug induced
- arterial hypertension
- pet ct